[1]
M. Bashir, “CONCORDANCE BETWEEN SERUM AND TISSUE EGFR MUTATIONS IN PATIENTS WITH ADENOCARCINOMA LUNG.”, jms, vol. 23, no. Suppl 1, Dec. 2020.